ICON (ICLR)
(Delayed Data from NSDQ)
$315.39 USD
+0.35 (0.11%)
Updated May 10, 2024 04:00 PM ET
After-Market: $314.10 -1.29 (-0.41%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum A VGM
Brokerage Reports
0 items in cart
ICON PLC [ICLR]
Reports for Purchase
Showing records 161 - 176 ( 176 total )
Company: ICON PLC
Industry: Medical Services
ICON Teams Up with IBM to Develop Predictive Analytics in Cancer Research
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: ICON PLC
Industry: Medical Services
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: ICON PLC
Industry: Medical Services
Strong 2Q15 Bookings Continues to Set Up Accelerated Growth in 2016
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Forget About Pfizer; Setting Up for Another Beat-and-Raise Year
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Quick Alert: Handily Beats with a 15.3% Operating Margin
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: ICON PLC
Industry: Medical Services
The Case for ICON -We are initiating coverage with a BUY rating
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: ICON PLC
Industry: Medical Services
Initiation of Coverage of Biopharmaceutical Services
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D